BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12503865)

  • 1. Persistence of Müllerian remnants in complete androgen insensitivity syndrome.
    Damiani D; Mascolli MA; Almeida MJ; Jaubert F; Fellous M; Dichtchekenian V; Tobo PR; Moreira-Filho CA; Setian N
    J Pediatr Endocrinol Metab; 2002; 15(9):1553-6. PubMed ID: 12503865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Müllerian derivatives: comparison with normal fetal development.
    Corbetta S; Muzza M; Avagliano L; Bulfamante G; Gaetti L; Eller-Vainicher C; Beck-Peccoz P; Spada A
    Fertil Steril; 2011 Mar; 95(3):1119.e9-14. PubMed ID: 20971460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete androgen insensitivity syndrome and discordant Müllerian remnants: two cases with novel mutation in the androgen receptor.
    Güven A; Dursun F; Özkanlı S; Güçlüer B; Kuru Lİ
    J Pediatr Endocrinol Metab; 2013; 26(9-10):909-14. PubMed ID: 23729616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Persistent müllerian duct syndrome (males with uterus): a pediatric problem].
    Zeller J; Imbeaud S; Rey R; Adamsbaum C; Fourmaintraux A; Donnet J; van Kote G; Josso N; Chaussain JL
    Arch Pediatr; 1994 Nov; 1(11):991-7. PubMed ID: 7834048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ingestion of diethylstilbestrol during pregnancy. Its responsibility in the testicular feminization syndrome].
    Chryssicopoulos A; Kondi-Parhitis A; Kairi D; Vasiliadis T; Maragoudakis A
    Presse Med; 1990 Sep; 19(30):1397-400. PubMed ID: 2146621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel point mutations in complete androgen insensitivity syndrome with incomplete müllerian regression: two Taiwanese patients.
    Van YH; Lin JL; Huang SF; Luo CC; Hwang CS; Lo FS
    Eur J Pediatr; 2003 Nov; 162(11):781-4. PubMed ID: 13680382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-reversed phenotype in association with two novel mutations c.2494delA and c.T3004C in the ligand-binding domain of the androgen receptor gene.
    Galani A; Sofocleous C; Karahaliou F; Papathanasiou A; Kitsiou-Tzeli S; Kalpini-Mavrou A
    Fertil Steril; 2008 Nov; 90(5):2008.e1-4. PubMed ID: 18342859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prenatal exposure to diethylstilbestrol on Müllerian duct development in fetal male mice.
    Visser JA; McLuskey A; Verhoef-Post M; Kramer P; Grootegoed JA; Themmen AP
    Endocrinology; 1998 Oct; 139(10):4244-51. PubMed ID: 9751506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Müllerian derivatives in males.
    Belville C; Josso N; Picard JY
    Am J Med Genet; 1999 Dec; 89(4):218-23. PubMed ID: 10727997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome.
    Coutant R; Mallet D; Lahlou N; Bouhours-Nouet N; Guichet A; Coupris L; Croué A; Morel Y
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2868-73. PubMed ID: 17488792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants of the anti-Müllerian hormone gene in a compound heterozygote with the persistent Müllerian duct syndrome and his family.
    Carré-Eusèbe D; Imbeaud S; Harbison M; New MI; Josso N; Picard JY
    Hum Genet; 1992 Dec; 90(4):389-94. PubMed ID: 1483695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of anti-müllerian hormone, 3 beta-hydroxysteroid dehydrogenase and androgen receptor expression during ovine total gonadal development.
    Sweeney T; Saunders PT; Millar MR; Brooks AN
    J Endocrinol; 1997 Apr; 153(1):27-32. PubMed ID: 9135566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the anti-müllerian hormone gene as cause of persistent müllerian duct syndrome.
    Lang-Muritano M; Biason-Lauber A; Gitzelmann C; Belville C; Picard Y; Schoenle EJ
    Eur J Pediatr; 2001 Nov; 160(11):652-4. PubMed ID: 11760020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of the persistent müllerian duct syndrome: a study of 19 families.
    Imbeaud S; Carré-Eusèbe D; Rey R; Belville C; Josso N; Picard JY
    Hum Mol Genet; 1994 Jan; 3(1):125-31. PubMed ID: 8162013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor.
    Imbeaud S; Faure E; Lamarre I; Mattéi MG; di Clemente N; Tizard R; Carré-Eusèbe D; Belville C; Tragethon L; Tonkin C; Nelson J; McAuliffe M; Bidart JM; Lababidi A; Josso N; Cate RL; Picard JY
    Nat Genet; 1995 Dec; 11(4):382-8. PubMed ID: 7493017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular feminization with incomplete Müllerian regression.
    Dodge ST; Finkelston MS; Miyazawa K
    Fertil Steril; 1985 Jun; 43(6):937-8. PubMed ID: 3838948
    [No Abstract]   [Full Text] [Related]  

  • 17. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.
    Rey R; al-Attar L; Louis F; Jaubert F; Barbet P; Nihoul-Fékété C; Chaussain JL; Josso N
    Am J Pathol; 1996 May; 148(5):1689-98. PubMed ID: 8623936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular biology of the persistent Müllerian duct syndrome].
    Imbeaud S; Josso N; Belville C; Messika-Zeitoun L; Rey R; Picard JY
    Contracept Fertil Sex; 1996 Sep; 24(9):613-6. PubMed ID: 8998503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of SOX9 in sertoli cells from testiculopathic patients accounts for increasing anti-mullerian hormone expression via impaired androgen receptor signaling.
    Lan KC; Chen YT; Chang C; Chang YC; Lin HJ; Huang KE; Kang HY
    PLoS One; 2013; 8(10):e76303. PubMed ID: 24098470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy birth after testicular extraction of sperm and ICSI from an azoospermic man with mild androgen insensitivity syndrome caused by an androgen receptor partial loss-of-function mutation.
    Massin N; Bry H; Vija L; Maione L; Constancis E; Haddad B; Morel Y; Claessens F; Young J
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):593-8. PubMed ID: 22469007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.